In consultation: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346] | Draft guidance | Technology appraisal guidance |